Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.

已完结 20 由 long 发布于 2026/3/6 15:03:32

DOI:10.7326/M15-0308
作者：Shuo-Ming Ou, Chia-Jen Shih, Pei-Wen Chao, Hsi Chu, Shu-Chen Kuo, Yi-Jung Lee, Shuu-Jiun Wang, Chih-Yu Yang, Chih-Ching Lin, Tzeng-Ji Chen, Der-Cherng
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.7326/M15-0308

其它数据库

Abstract：Background: Recent studies concluded that dipeptidyl peptidase-4 (DPP-4) inhibitors provide glycemic control but also raised concerns about the risk for heart failure in patients with type 2

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierPLGA-based microspheres loaded with metformin hydrochloride: Modified double emulsion method preparation, optimization, characterization, and in vitro evaluation